Business Description
Sanara MedTech Inc
NAICS : 333310
SIC : 3843
ISIN : US79957L1008
Total Employee Number:
108Description
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.28 | |||||
Equity-to-Asset | 0.1 | |||||
Debt-to-Equity | 6.88 | |||||
Debt-to-EBITDA | 5.52 | |||||
Interest Coverage | 1.17 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.8 | |||||
Beneish M-Score | -5.03 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 27.3 | |||||
3-Year Book Growth Rate | -49.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 70.64 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 13.82 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 65 | |||||
9-Day RSI | 61.85 | |||||
14-Day RSI | 60.18 | |||||
3-1 Month Momentum % | 18.24 | |||||
6-1 Month Momentum % | -12.05 | |||||
12-1 Month Momentum % | -28.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.28 | |||||
Quick Ratio | 2.05 | |||||
Cash Ratio | 0.99 | |||||
Days Inventory | 164.29 | |||||
Days Sales Outstanding | 41.79 | |||||
Days Payable | 77.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.5 | |||||
Shareholder Yield % | -7.04 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 92.92 | |||||
Operating Margin % | 7.86 | |||||
Net Margin % | -31.23 | |||||
EBITDA Margin % | 8.15 | |||||
FCF Margin % | 3.12 | |||||
OCF Margin % | 5.88 | |||||
ROE % | -184.11 | |||||
ROA % | -41.1 | |||||
ROIC % | 13.77 | |||||
3-Year ROIIC % | 484.58 | |||||
ROC (Joel Greenblatt) % | 88.8 | |||||
ROCE % | 8.09 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 146.59 | |||||
PS Ratio | 2.03 | |||||
PB Ratio | 32.42 | |||||
Price-to-Free-Cash-Flow | 63.11 | |||||
Price-to-Operating-Cash-Flow | 33.88 | |||||
EV-to-EBIT | 49.1 | |||||
EV-to-EBITDA | 29.99 | |||||
EV-to-Revenue | 2.44 | |||||
EV-to-Forward-Revenue | 2.13 | |||||
EV-to-FCF | 78.4 | |||||
Price-to-GF-Value | 0.54 | |||||
Price-to-Median-PS-Value | 0.69 | |||||
Earnings Yield (Greenblatt) % | 2.04 | |||||
FCF Yield % | 1.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SMTI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sanara MedTech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 107.51 | ||
| EPS (TTM) ($) | -3.89 | ||
| Beta | 1.7971 | ||
| 3-Year Sharpe Ratio | -0.21 | ||
| 3-Year Sortino Ratio | -0.31 | ||
| Volatility % | 63.26 | ||
| 14-Day RSI | 60.18 | ||
| 14-Day ATR ($) | 1.495382 | ||
| 20-Day SMA ($) | 23.3025 | ||
| 12-1 Month Momentum % | -28.39 | ||
| 52-Week Range ($) | 16.0465 - 35.95 | ||
| Shares Outstanding (Mil) | 9.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sanara MedTech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sanara MedTech Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-12 08:00 | In 122 days | ||
| Third quarter earnings results for 2026 | 2026-11-12 | In 121 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-13 08:00 | In 31 days | ||
| Second quarter earnings results for 2026 | 2026-08-13 | In 30 days | ||
| General meeting for 2026 | 2026-06-04 10:00 | 20.97 (-1.36%) | ||
| First quarter earnings conference call for 2026 | 2026-05-12 08:00 | 18.02 (-2.07%) | ||
| First quarter earnings results for 2026 | 2026-05-12 | 18.02 (-2.07%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-24 08:00 | 18.34 (-2.19%) | ||
| Annual report for 2025 | 2026-03-24 | 18.34 (-2.19%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-24 | 18.34 (-2.19%) |
Show
Entries
Sanara MedTech Inc Frequently Asked Questions
What is Sanara MedTech Inc(SMTI)'s stock price today?
The current price of SMTI is $24.87. The 52 week high of SMTI is $35.95 and 52 week low is $16.05.
When is next earnings date of Sanara MedTech Inc(SMTI)?
The next earnings date of Sanara MedTech Inc(SMTI) is 2026-08-13 Est..
Does Sanara MedTech Inc(SMTI) pay dividends? If so, how much?
Sanara MedTech Inc(SMTI) does not pay dividend.
Guru Commentaries on NAS:SMTI
No articles.
Press Release
Articles on Sanara MedTech Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers